A carregar...
Dasatinib Inhibits Procoagulant and Clot Retracting Activities of Human Platelets
Tyrosine kinase inhibitors (TKI) such as the BCR-ABL inhibitor dasatinib and nilotinib are highly effective therapies for chronic myeloid leukemia (CML). However, several lines of evidence suggest that dasatinib can induce bleeding which may be due to impaired collagen-induced platelet adhesion, agg...
Na minha lista:
| Publicado no: | Int J Mol Sci |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6862041/ https://ncbi.nlm.nih.gov/pubmed/31683623 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20215430 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|